Hôpital Paris Saint-Joseph

Running trials

• Not yet recruiting

  Exposure to Persistent Organic Pollutants and Severity of Endometriosis in the ComPaRe-Endometriosis Cohort

  NCT06973603· Institut National de la Santé Et de la Recherche Médicale, France· Source

• Not yet recruiting

  Carotid Ultrasound-based Assessment of Maternal Hemodynamics to Guide HYpertension Treatment in PREgnancy - Pilot Study

  NCT07932171· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial

  NCT06811402· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· Phase 1/2· Daiichi Sankyo· Source

• Recruiting

  CLE-PAD : Prevalence of PAD in Patients With Surgically Lumbar Spinal Stenosis

  NCT07469020· Rennes University Hospital· Source

• Not yet recruiting

  Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)

  NCT07603440· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

  NCT07483983· Phase 2· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

  NCT06629363· Centre Hospitalier de PAU· Source

• Recruiting

  The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

  NCT07211126· Tandem Diabetes Care, Inc.· Source

• Recruiting

  Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography

  NCT07512830· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  Evaluation of the Effect of Music During Nursing Care on the Confort of Patient Hospitalized in Intensive Care Unit During the Acute Phase of a Stroke

  NCT07313163· Fondation Hôpital Saint-Joseph· Source

• Not yet recruiting

  Prevalence and Functional Impact of Urinary Incontinence in Women With Chronic Obstructive Pulmonary Disease Undergoing Rehabilitation: a Cross-sectional Study

  NCT07134400· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  NCT07227298· Phase 1/2· Pfizer· Source

• Recruiting

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· Phase 2/3· Bristol-Myers Squibb· Source

• Recruiting

  A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  NCT07213674· Phase 3· Amgen· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

  NCT07190248· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· Phase 2/3· Bristol-Myers Squibb· Source

• Recruiting

  First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

  NCT06840782· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

  NCT07136467· AbbVie· Source

• Active, not recruiting

  Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis

  NCT07175857· Lyv Healthcare· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Gilead Sciences· Source

• Recruiting

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· Phase 4· Insel Gruppe AG, University Hospital Bern· Source

• Not yet recruiting

  Prevalence of Central Neuropathic Pain After a Stroke in Patients Attending Post-stroke Consultations in the Île-de-France Region

  NCT06813391· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  NCT06764693· AbbVie· Source

• Recruiting

  Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

  NCT06784193· Phase 1· Olema Pharmaceuticals, Inc.· Source

• Recruiting

  Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245· Phase 3· OSE Immunotherapeutics· Source

• Recruiting

  Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer

  NCT06582628· Phase 2· Fundacion Oncosur· Source

• Recruiting

  Contribution of Myocardial Perfusion Imaging in the Initial Assessment of Acute Coronary Syndromes Without ST Elevation for the Diagnosis of Myocardial Infarction or Differential Diagnoses

  NCT07112820· Fondation Hôpital Saint-Joseph· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional Study

  NCT06339567· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"

  NCT07086599· Fondation Hôpital Saint-Joseph· Source

• Recruiting

  PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

  NCT05387954· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study

  NCT05692999· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

  NCT05002556· Association Francaise d'Urologie· Source

• Active, not recruiting

  A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

  NCT05668988· Phase 3· Dizal Pharmaceuticals· Source

• Recruiting

  Met Non Small Cell Cancer Registry (MOMENT)

  NCT05376891· EMD Serono Research & Development Institute, Inc.· Source

• Active, not recruiting

  Contribution of Cardiac MRI in the Early Diagnosis of Myocarditis Induced by Immunotherapy

  NCT05125965· Centre Chirurgical Marie Lannelongue· Source

• Recruiting

  Prospective Cohort of Patients With Critical Limb Ischemia Undergoing Revascularization

  NCT04312451· Fondation Hôpital Saint-Joseph· Source

• Active, not recruiting

  Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

  NCT04907240· W.L.Gore & Associates· Source

• Recruiting

  Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

  NCT04428554· Phase 2· Institut Claudius Regaud· Source

• Active, not recruiting

  A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.

  NCT03884257· KANDO Research· Source

• Recruiting

  French Registry for Monitoring Pregnancies for Multiple Sclerosis

  NCT03900221· Hospices Civils de Lyon· Source

• Active, not recruiting

  Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy

  NCT03977194· Phase 3· Intergroupe Francophone de Cancerologie Thoracique· Source

• Active, not recruiting

  A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

  NCT03148418· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

  NCT02834884· European Organisation for Research and Treatment of Cancer - EORTC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer12 recruiting
• Stroke6 recruiting
• Bladder cancer3 recruiting
• Prostate cancer3 recruiting
• Childhood cancers2 recruiting
• COPD2 recruiting
• High blood pressure2 recruiting
• Peripheral artery disease2 recruiting
• Psoriasis2 recruiting
• Alopecia areata1 recruiting
• Coronary artery disease1 recruiting
• Endometriosis1 recruiting
• Hidradenitis suppurativa1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple sclerosis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Pancreatic cancer1 recruiting
• Psoriatic arthritis1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 1 diabetes1 recruiting
• Vitiligo1 recruiting

Closed trials

• Terminated

  A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

  NCT05983367· Phase 2· Inspirna, Inc.· Source

• Completed

  Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures

  NCT05831319· Biotronik AG· Source

• Completed

  A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

  NCT05560646· Phase 2· Organon and Co· Source

• Completed

  Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

  NCT05399680· Cordis US Corp.· Source

• Completed

  Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease

  NCT05192616· iVascular S.L.U.· Source

• Recruiting

  Environment and Lung Cancer

  NCT05119244· Centre Chirurgical Marie Lannelongue· Source

• Completed

  A Study of Surgical Interventions in Fistulizing Conditions

  NCT04940611· Takeda· Source

• Recruiting

  Abbott Vascular Medical Device Registry

  NCT04573660· Abbott Medical Devices· Source

• Completed

  Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

  NCT04075825· Phase 3· Takeda· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source

• Completed

  The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

  NCT03551496· Phase 3· Boston Scientific Corporation· Source

• Completed

  Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)

  NCT03674424· Phase 2· Jules Bordet Institute· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

• Completed

  Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

  NCT02738125· AbbVie· Source

• Completed

  Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy

  NCT02514278· Phase 3· University Hospital, Bordeaux· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Aortic aneurysm14 works · 0 trials
• Peripheral artery disease7 works · 10 trials